Literature DB >> 30546662

Impella CP-assisted balloon aortic valvuloplasty.

Michael Megaly1, Paul Jones2.   

Abstract

Percutaneous ventricular assist device (PVAD) use in balloon aortic valvuloplasty (BAV) has been performed sporadically. The PVAD used was TandemHeart. A few cases were reported using Impella 2.5 device. We report the first case of Impella CP-assisted BAV. The use of PVAD has been contraindicated in severe aortic stenosis (AS). However, the various benefits of PVAD, including circulatory support and minimizing interruption of blood flow during balloon inflation, made its use attractive in high-risk BAV. We recommend that severe AS no more stays as a contraindication to the use of PVADs. <Learning objective: There are various benefits of using percutaneous ventricular assist devices (PVADs) during high-risk balloon aortic valvuloplasty (BAV). Benefits, including circulatory support and minimizing interruption of blood flow during balloon inflation, made its use attractive in high-risk BAV. We present the good outcome of using Impella CP device in one case of high-risk BAV. We recommend that severe aortic stenosis no more stays as a contraindication to the use of PVADs.>.

Entities:  

Keywords:  Balloon aortic valvuloplasty; Impella CP device; PVAD-assisted balloon aortic valvuloplasty; Severe aortic stenosis

Year:  2016        PMID: 30546662      PMCID: PMC6282924          DOI: 10.1016/j.jccase.2016.03.012

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  5 in total

1.  Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.

Authors:  Claudia A Martinez; Vikas Singh; Juan C Londoño; Mauricio G Cohen; Carlos E Alfonso; William W O'Neill; Alan W Heldman
Journal:  Catheter Cardiovasc Interv       Date:  2012-04-17       Impact factor: 2.692

2.  Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years.

Authors:  Ajay Agarwal; Annapoorna S Kini; Srinivas Attanti; Paul C Lee; Ramin Ashtiani; Angelica M Steinheimer; Pedro R Moreno; Samin K Sharma
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

3.  Impella 2.5 assisted balloon aortic valvuloplasty and percutaneous coronary intervention as a bridge to heart transplantation.

Authors:  Ramy A Badawi; Mark A Grise; Stanley N Thornton
Journal:  J Invasive Cardiol       Date:  2012-05       Impact factor: 2.022

4.  Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk patient.

Authors:  Juan C Londoño; Claudia A Martinez; Vikas Singh; William W O'Neill
Journal:  J Interv Cardiol       Date:  2011-01-11       Impact factor: 2.279

5.  Impella-assisted balloon aortic valvuloplasty.

Authors:  Daniel J Ludeman; Bryan G Schwartz; Steven Burstein
Journal:  J Invasive Cardiol       Date:  2012-01       Impact factor: 2.022

  5 in total
  1 in total

Review 1.  Ventricular Unloading Using the ImpellaTM Device in Cardiogenic Shock.

Authors:  Adrian Attinger-Toller; Matthias Bossard; Giacomo Maria Cioffi; Gregorio Tersalvi; Mehdi Madanchi; Andreas Bloch; Richard Kobza; Florim Cuculi
Journal:  Front Cardiovasc Med       Date:  2022-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.